JPMORGAN CHASE & CO - ESPERION THERAPEUTICS INC NE ownership

ESPERION THERAPEUTICS INC NE's ticker is and the CUSIP is 29664W955. A total of 4 filers reported holding ESPERION THERAPEUTICS INC NE in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
JPMORGAN CHASE & CO ownership history of ESPERION THERAPEUTICS INC NE
ValueSharesWeighting
Q3 2020$11,000
-99.9%
300
-99.8%
0.00%
-100.0%
Q2 2020$8,210,000
+149.4%
160,000
+90.5%
0.00%
+100.0%
Q2 2018$3,292,000
+11.1%
84,000
+86.7%
0.00%0.0%
Q4 2017$2,963,00045,0000.00%
Other shareholders
ESPERION THERAPEUTICS INC NE shareholders Q3 2020
NameSharesValueWeighting ↓
GROUP ONE TRADING, L.P. 11,200$416,0000.00%
SIMPLEX TRADING, LLC 156$579,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
JPMORGAN CHASE & CO 300$11,0000.00%
View complete list of ESPERION THERAPEUTICS INC NE shareholders